Non-communicable diseases (NCDs), such as heart disease and diabetes, are responsible for over 70% of global deaths, posing a major public health challenge rooted in lifestyle and behavior. Unlike infectious diseases, which can be addressed through broad interventions like vaccines, NCDs require individualized strategies that consider personal habits, medical history, and environmental factors. Emerging artificial intelligence (AI) technologies are now enabling scalable, personalized health guidance by integrating fragmented data sources—from wearable devices to clinical records—into actionable insights.
Traditional public health measures, including smoking bans and sugar taxes, have had limited success due to inconsistent enforcement and lack of personal relevance. AI systems can overcome these limitations by analyzing vast datasets to identify patterns and predict health outcomes. For example, analysis of over 500,000 individuals aged 45 to 65 found that increasing physical activity from none to moderate or high levels reduced mortality risk by 38% and 58%, respectively. The benefits are even greater for older or less healthy individuals: an unhealthy 70-year-old who adopts healthier habits could see lifespan increase by 45% and healthspan by 90%.
Behavioral changes also compound over time. Research suggests most people form strong habits within seven to 15 weeks. Those who sustain moderate exercise reduce common-cause mortality risk by 27%. Similarly, walking 7,500 steps five times a week for two years lowers the risk of type 2 diabetes by 41% and stage 4 cancer by 36%.
Despite the availability of health data, it remains scattered across devices, clinics, insurers, and labs. Few platforms offer a comprehensive view that includes biometrics, clinical history, insurance claims, and behavioral trends. AI-powered systems like Vitality AI—a collaboration between Vitality and Google—leverage advanced analytics and machine learning models to unify these sources. The result is tailored recommendations on physical activity, sleep, screenings, chronic disease management, and wellness coaching.
Such tools have already demonstrated impact. AI-driven screening suggestions have increased screening rates by 1.22 times and improved early cancer detection by 19%. MediKarma, another platform, uses AI to analyze medical records and lifestyle inputs, offering step-by-step prevention plans and prompting users to discuss key concerns with their doctors. Ada Health, operating in the U.S. and globally, combines clinical knowledge with AI to deliver diagnostic support. In a maternal health pilot in South Africa, 98% of its urgency assessments were validated by clinicians, and one in three women altered their healthcare-seeking behavior after using the service.
However, awareness alone does not guarantee action. To drive sustained change, behavioral incentives are essential. By analyzing engagement tendencies, motivational triggers, and communication preferences, AI systems can deliver personalized rewards—such as discounts or premium reductions—that increase adherence.
Insurers are uniquely positioned to leverage these tools. As stakeholders in long-term health outcomes, they benefit from reduced claims and improved customer longevity. Moreover, they can reinvest savings into incentive programs, creating a self-reinforcing cycle: healthier behaviors lead to lower costs, which fund further engagement, leading to even better outcomes. This model not only enhances individual well-being but also strengthens industry sustainability and reduces societal disease burden.
— news from The World Economic Forum
— News Original —
How AI-powered solutions enable preventive health at scale
Non-communicable diseases represent a global behavioural crisis requiring personalized interventions rather than generic public health measures. n nAI technologies can now integrate fragmented data to deliver scalable, hyper-personalized health recommendations for better outcomes. n nInsurers can leverage these AI-driven insights and incentives to encourage sustainable behaviour change, improving global longevity. n nFive years after the pandemic, the world’s greatest health crisis isn’t infectious, it’s behavioural. Non-communicable diseases (NCDs) like heart disease and diabetes are the biggest drivers of mortality globally, yet existing public health interventions haven’t gone far enough in addressing the behaviours that underpin these conditions. Unlike infectious diseases, which require widescale generic remedies like vaccinations, diseases of lifestyle often require tailored guidance based on an individual’s specific context. n nTo date, this has been hindered by various factors, including the fragmented nature of personal health data. New AI capabilities, however, are making it possible to provide hyper-personalized health recommendations at scale – with the potential to dramatically improve global health outcomes. n nNCDs are a macro problem, but require intervention at a personal level n nNon-communicable diseases account for more than 70% of all deaths globally – every minute, more than 70 people die from these largely preventable conditions. Existing public health initiatives like smoke-free laws, excise taxes and advertising bans can be effective but issues with design, enforcement and compliance remain. Critically, these interventions lack key contextual elements that can make or break behaviour change. We need mechanisms to deliver health guidance at a personal level, which means equipping people with the knowledge of both what to do and how to do it. n nDiscover n nWhat is the World Economic Forum doing to improve healthcare systems? n nThe Global Health and Strategic Outlook 2023 highlighted that there will be an estimated shortage of 10 million healthcare workers worldwide by 2030. n nThe World Economic Forum’s Centre for Health and Healthcare works with governments and businesses to build more resilient, efficient and equitable healthcare systems that embrace new technologies. n nLearn more about our impact: n nGlobal vaccine delivery: Our contribution to COVAX resulted in the delivery of over 1 billion COVID-19 vaccines and our efforts in launching Gavi, the Vaccine Alliance, has helped save more than 13 million lives over the past 20 years. n nDavos Alzheimer’s Collaborative: Through this collaborative initiative, we are working to accelerate progress in the discovery, testing and delivery of interventions for Alzheimer’s – building a cohort of 1 million people living with the disease who provide real-world data to researchers worldwide. n nMental health policy: In partnership with Deloitte, we developed a comprehensive toolkit to assist lawmakers in crafting effective policies related to technology for mental health. n nGlobal Coalition for Value in Healthcare: We are fostering a sustainable and equitable healthcare industry by launching innovative healthcare hubs to address ineffective spending on global health. In the Netherlands, for example, it has provided care for more than 3,000 patients with type 1 diabetes and enrolled 69 healthcare providers who supported 50,000 mothers in Sub-Saharan Africa. n nUHC2030 Private Sector Constituency: This collaboration with 30 diverse stakeholders plays a crucial role in advocating for universal health coverage and emphasizing the private sector’s potential to contribute to achieving this ambitious goal. n nWant to know more about our centre’s impact or get involved? Contact us. n nThe power of behaviour change n nOur data set, spanning 60 million life years, across 80 sources and 2,800 dimensions, validates the power of behaviour change. n nThe first powerful observation from our data is causality, namely, a change in behaviour can be proven to cause a change in health outcomes. For example, an analysis of more than 500,000 participants over five years showed that those aged 45 to 65 years who transitioned from no exercise to medium or high levels of exercise saw a 38% and 58% decrease in mortality risk, respectively. n nWe also see that this effect is elastic and universal; in other words, just a few changes in behaviour deliver dramatic increases in lifespan and healthspan, and the effect increases for those who are older and have more health conditions. n nBased on Vitality data, a moderately healthy 30-year-old can increase their lifespan by 6% and their healthspan by 7% through a few key actions, but an unhealthy 70-year-old can see a 45% increase in lifespan and a staggering 90% increase in healthspan by changing behaviour. You are never too old or too sick to become healthier. n nAnd lastly, behaviour change compounds through its habitual nature. Habits can form quickly and easily for many people, and once a strong habit is formed, health outcomes improve dramatically. Previous research shows it takes most people seven to 15 weeks to form a strong habit, and individuals who sustain a habit of moderate-intensity exercise reduce their common-cause mortality risk by 27%. Healthy habits also reduce specific disease risk: those who do 7,500 steps five times per week for two years can reduce their risk of type 2 diabetes by 41% and of stage 4 cancer by 36%. n nHealth data is dispersed and fragmented n nWe have made the case for how powerful behaviour change is in terms of extending lifespan and healthspan. But there’s an important caveat – precision is required to get the right impact. We need to know with absolute accuracy the specific lifestyle changes a given individual needs to take, with a longitudinal perspective of how that behaviour change will impact their mortality and morbidity over time. n nA number of industries have emerged to solve this problem – devices, wearables, lab testing platforms, health coaches – but they often function in isolation and typically only cover a few metrics of health. Often these platforms don’t have insights into clinical data from hospitals and doctors, or insurance claims data and mortality patterns over time. To overcome this, one needs massive amounts of computing power and complex technology to make sense of the fragmented data. n nMoving from collection to connection n nThanks to the recent progression of artificial intelligence (AI), new opportunities are emerging to tackle this challenge. One example is Vitality AI, a partnership between Vitality and Google, which combines Google’s AI and data analytics capabilities, including Vertex AI and Gemini models, with Vitality’s diverse and longitudinal range of healthspan and lifespan data. This makes it possible to coalesce disparate data sources into a single technology platform that is easy to scale. n nThe output is hyper-relevant and personalized health recommendations to millions of customers. These recommendations include lifestyle choices like physical activity and sleep, as well as screenings, chronic disease management, and wellness coaching. n nBased on Discovery data, AI-powered, personalized screening recommendations have already led to a 1.22x increase in screening rates and a 19% improvement in early cancer detection, underscoring the power of targeted prevention. n nAnother example of how AI is enabling data integration is MediKarma, a health tech platform that uses AI and data analytics to personalize wellness, prevention and care navigation. By analysing medical records, biometric data and behavioural inputs, MediKarma offers step-by-step guidance to help individuals stay ahead of health issues and make more informed decisions about their care – while prompting relevant questions to discuss with their physician. n nThere’s also Ada Health, a US company that combines clinical expertise and advanced AI to help people and health organizations act on insights earlier. Ada’s platform integrates medical history, lifestyle data and wearable inputs to provide personalized diagnostic suggestions and next steps. In a maternal health study based in South Africa, called “SafeMom”, 98% of Ada’s urgency advice was deemed safe by clinicians and around one in three women changed their initial health‐seeking plan after using the service. n nEngagement: The missing link n nYet, even when people know what to do, they don’t always do it. That’s why incentives are needed. This moves us from what to do per individual, to how to effect change. By layering insights from different data sources, including people’s propensity to engage in actions, the incentives likely to motivate them, and the communication style that most resonates with them, it’s possible to offer personalized rewards with the best chance of incentivizing change per individual. We can now scale this capability through the partnership with Google. n nThese AI-enabled models are not only revolutionizing health and changing people’s lives, they are also set to transform one of the largest and most influential industries in the world – insurance. The interaction between insurance and health-related behaviour change is bi-directional: Life and health insurers stand to benefit enormously from improvements in health and mortality because they are invested in the health and longevity of people’s lives. n nAt the same time, insurers are one of the only actors that can monetize improvements in health and are therefore perfectly positioned to drive change at scale: they can act as funders for health improvements, channelling additional profits from behaviour change into the rewards and incentives that ensure that very behaviour change continues to happen. n nIt’s a virtuous cycle that benefits individuals, insurers and society: the individual through better health and rewards; the industry through better profitability, lower claims and increased competitiveness; and society by lowering the disease burden and creating a healthier, more productive population.